B3 lesion upgrade rates in a tertiary Australian breast centre: a 8‐year experience (2012–2019)

YY Huang, H Park, S McLaren… - ANZ journal of …, 2020 - Wiley Online Library
Background B3 breast lesions identified on core needle biopsy have uncertain malignant
potential. Traditional management of these lesions has been surgical excision, but there is …
被引用次数：10 相关文章

B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019).

YY Huang, H Park, S McLaren… - ANZ Journal of …, 2020 - europepmc.org
Background B3 breast lesions identified on core needle biopsy have uncertain malignant
potential. Traditional management of these lesions has been surgical excision, but there is …

B3 lesion upgrade rates in a tertiary Australian breast centre: a 8‐year experience (2012–2019).

YY Huang, H Park, S McLaren… - ANZ Journal of …, 2020 - search.ebscohost.com
Background: B3 breast lesions identified on core needle biopsy have uncertain malignant
potential. Traditional management of these lesions has been surgical excision, but there is …

B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019)

YY Huang, H Park, S McLaren… - ANZ journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background B3 breast lesions identified on core needle biopsy have uncertain malignant
potential. Traditional management of these lesions has been surgical excision, but there is …

B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012–2019)

YY Huang, H Park, S McLaren… - ANZ Journal …, 2020 - research-repository.uwa.edu.au
Background: B3 breast lesions identified on core needle biopsy have uncertain malignant
potential. Traditional management of these lesions has been surgical excision, but there is …